On November 13, Aehr Test falls 5.19% in Regular Trading, trading at $57.96/share, with turnover of $17.6366 million.
The move followed continued cooling in the market’s post-earnings trading momentum after investors had previously bid up the stock on stronger-than-expected quarterly results, a higher full-year revenue outlook, and progress in AI chip testing orders and deployments.
Previously disclosed results showed adjusted first-quarter EPS of $0.28 versus expectations of $0.11 and revenue of $33.007 million versus $27.072 million expected. The company also reported backlog of $100.9 million as of September 25 and highlighted deployment progress with a major AI accelerator customer, including a fully configured FOX-XP wafer-level burn-in system planned for installation at a partner facility in Taiwan in early 2027. After the earlier sharp rally, the marginal boost from those positives appears to have faded, with trading turning more cautious.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments